Ventricular arrhythmias and sudden death events following acalabrutinib initiationSeema A. Bhat, Daniel Addison, John C. Byrd et al.|Blood|2022Cited by 68
Hypertension and incident cardiovascular events after next-generation BTKi therapy initiationSunnia T. Chen, Daniel Addison, Jennifer A. Woyach et al.|Journal of Hematology & Oncology|2022Cited by 36